 - The effects of everolimus and imatinib on the developing human fetus are unknown. For this reason, women of child-bearing potential and men must agree to use adequate contraception barrier method of birth control; abstinence prior to study entry, for the duration of study participation and 3 months after stopping study drug. Should a woman or the partner of a man participating in this trial become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately. 